You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Treatment parameters used for SBRT

From: Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer

  All lesions Lesions with local control Lesions without local control
GTV (ml) 23.9 (2.5–115.3) 17.8 (2.5–75) 60.7 (26.4–115.3)
Maximum dose (Gy) 58 (43.2–70.4) 57.7 (43.2–70.4) 58.6 (44.9–66.2)
Total prescribed dose (Gy) 44.4 (32–50) 45 (32–50) 41.6 (35–45)
Number of fractions 5 (3–8) 5 (3–8) 5 (3–8)
Dose per fraction (Gy) 9 (4–15) 9 (4–15) 7 (5.2–15)
BED10 (Gy) 85.5 (44.8–112.5) 85.5 (44.8–112.5) 67.2 (59.5–112.5)
Prescription isodose line (%) 73 (66–82) 74 (66–82) 71 (66–79)
  1. All data were shown as median values (range)